top of page
Every person with, or at risk of, cardiomyopathy must have timely access to optimal care that addresses their unique needs and improves their quality of life.
The International Cardiomyopathy Network (ICoN) is a newly established association of medical, scientific and lay stakeholders with the mission of improving the health of people affected by cardiomyopathy and related diseases. ICoN plans to undertake a rolling programme to transform the cardiomyopathy landscape in Europe through clinical education and patient engagement, so that more people with cardiomyopathy can access the treatment and support that they need when they need it. ICoN recently published its manifesto for the future of cardiomyopathy care which you can read here.
The International Cardiomyopathy Network is supported by Bristol Myers Squibb, Illumina, Tenaya, Sanofi and AstraZeneca
bottom of page